NPPB and hydrops fetalis: Natriuretic peptide, and specifically NT-proBNP levels, are used for the diagnostic and prognostic evaluation of HF, and several previous clinical trials have shown that there is possible heterogeneity in the response to treatment according to baseline NT-proBNP levels in patients with HFrEF or with HFpEF [60].